Leif Bjermer

Research interests

Publications

• Exploring Definitions and Predictors of Severe Asthma Clinical Remission after Biologic Treatment in Adults

  American Journal of Respiratory and Critical Care Medicine · 2024 · https://doi.org/10.1164/rccm.202311-2192oc

• Eosinophilic and Noneosinophilic Asthma

  CHEST Journal · 2021 · https://doi.org/10.1016/j.chest.2021.04.013

• EUFOREA consensus on biologics for CRSwNP with or without asthma

  Allergy · 2019 · https://doi.org/10.1111/all.13875

• Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases

  Clinical and Translational Allergy · 2019 · https://doi.org/10.1186/s13601-019-0279-2

• Benralizumab for the Prevention of COPD Exacerbations

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1905248

• Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels

  CHEST Journal · 2016 · https://doi.org/10.1016/j.chest.2016.03.032

• Tiotropium + olodaterol shows clinically meaningful improvements in quality of life

  Respiratory Medicine · 2015 · https://doi.org/10.1016/j.rmed.2015.08.002

• Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2–4)

  European Respiratory Journal · 2015 · https://doi.org/10.1183/09031936.00136014

• Current evidence and future research needs for FeNO measurement in respiratory diseases

  Respiratory Medicine · 2014 · https://doi.org/10.1016/j.rmed.2014.02.005

• IL-9 Governs Allergen-induced Mast Cell Numbers in the Lung and Chronic Remodeling of the Airways

  American Journal of Respiratory and Critical Care Medicine · 2010 · https://doi.org/10.1164/rccm.200909-1462oc

• MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function

  Journal of Allergy and Clinical Immunology · 2010 · https://doi.org/10.1016/j.jaci.2010.04.004

• Exercise‐induced asthma, respiratory and allergic disorders in elite athletes: epidemiology, mechanisms and diagnosis: Part I of the report from the Joint Task Force of the European Respiratory Society (ERS) and the European Academy of Allergy and Clinical Immunology (EAACI) in cooperation with GA2LEN

  Allergy · 2008 · https://doi.org/10.1111/j.1398-9995.2008.01662.x

• Achieving asthma control in practice: Understanding the reasons for poor control

  Respiratory Medicine · 2008 · https://doi.org/10.1016/j.rmed.2008.08.003

• Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial

  Clinical & Experimental Allergy · 2005 · https://doi.org/10.1111/j.1365-2222.2005.02251.x

• How representative are clinical study patients with asthma or COPD for a larger “real life” population of patients with obstructive lung disease?

  Respiratory Medicine · 2004 · https://doi.org/10.1016/j.rmed.2004.03.026

• Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial

  BMJ · 2003 · https://doi.org/10.1136/bmj.327.7420.891

• Evidence of Airway Inflammation and Remodeling in Ski Athletes with and without Bronchial Hyperresponsiveness to Methacholine

  American Journal of Respiratory and Critical Care Medicine · 2000 · https://doi.org/10.1164/ajrccm.161.6.9907025

• Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness

  European Respiratory Journal · 1999 · https://doi.org/10.1034/j.1399-3003.1999.13b14.x

Current projects

No projects listed.